Le Lézard
Classified in: Health
Subjects: CHI, WOM, TRI

New Research in Obstetrics has Doctors Questioning one of the Oldest Rules of Baby Catching


TEMPE, Ariz., Aug. 6, 2018 /PRNewswire/ -- Olivia Orano has just delivered baby Myles, a beautiful 7lb baby boy!  Like any first time mothers, during the pregnancy, Olivia spent a lot of time developing a "birth plan," or a list of her preferences at time of delivery.  That list originally included avoiding induction of labor and "letting the baby come naturally."

At six months of pregnancy, however, Olivia had a discussion with her OBGYN that changed that plan.  Her OBGYN, Dr. Greg Marchand, told her about a recent study that gave new information about first time moms, and how they could maximize their chance of delivering vaginally and avoiding cesarean sections.

"I was always taught in my training that it was best to wait for labor, no matter how long that took," said Dr. Marchand, a leading Arizona OBGYN.  "I was taught that the way to maximize the patient's chance of a vaginal delivery was to avoid induction and let the woman go into labor naturally.  We couldn't have been more wrong!    If you're pregnant with your first baby, and you want to have your baby vaginally, you should be induced no later than 39 weeks.  For years, all Obstetricians, including myself, have been counselling our patients that they should wait for labor.  At least for first time mothers, this is now clearly not the best idea."

The landmark study came from the government funded National Institute of Child Health and Human Development (NICHD).  The results showed that those first time moms randomized to be induced at 39 weeks had a lower rate of cesarean section, and had babies that did better after birth.  The study seemed to prove that the definitive factor in whether a woman will deliver her baby vaginally or by cesarean section is the weight of the baby.  This stands in contrast to decades of traditional Obstetrical education which taught that cervical dilation was the real determinant.

Cervical dilation or "ripeness", refers to how open, or how soft the cervix is. Up until this point many Obstetricians would use this solely as the determinant for when to induce labor.  The study was sponsored by the National Institute of Health and prospectively reviewed the outcome of greater than 6000 births of first time mothers. About half of those mothers were scheduled for induction at 39 weeks, the other half were left to go into labor naturally whenever it would come. The surprising outcome was a 16% decrease in cesarean section in the women in the electively induced arm of the study.  The babies born to the electively induced babies also had a lower incidence of respiratory problems, and overall needed help breathing less often than the babies in the "natural labor" arm.

Dr. Marchand went on to explain that this research will greatly change the way doctors counsel their pregnant patients at time of delivery, and that it will result in many more women being induced at 39 weeks gestation.

For Olivia, she was moved by the discussion and decided to go forward with induction at 39 weeks.  She was able to have baby Myles naturally, and couldn't be more in love with her new baby!

Ms. Orano is interested in sharing her story with the news media for purposes of awareness.  For media and interview requests contact Maria Sainz at [email protected] or 480-999-0905

Dr. Greg J. Marchand is an OBGYN specializing in Minimally Invasive Surgery in Phoenix Arizona's East Valley. To learn more about Dr. Marchand's research, please visit:  www.GregMarchandMD.Com

To learn more about the referenced NICHD Study, please visit: http://www.ajog.org/article/S0002-9378(17)32491-2/pdf

SOURCE MARCHAND OBGYN PLLC


These press releases may also interest you

23 avr 2024
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

23 avr 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

23 avr 2024
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

23 avr 2024
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

23 avr 2024
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...

23 avr 2024
Astellas Pharma Inc....



News published on and distributed by: